Dr. Karl Damiani, M.D.
What this data tells you about Dr. Damiani
Dr. Karl Damiani is an infectious disease in Port Charlotte, FL, with 20 years in practice. Based on federal Medicare data, Dr. Damiani performed 984,728 Medicare services across 2,177 unique beneficiaries.
Between the years covered by Open Payments, Dr. Damiani received a total of $2,851 from 12 pharmaceutical and/or device companies across 53 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Damiani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 908,540 | $0 | $0 |
| Injection, micafungin sodium, 1 mg | 43,100 | $1 | $3 |
| Injection, cefepime hydrochloride, 500 mg | 6,630 | $1 | $10 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 5,182 | $48 | $150 |
| Infusion, normal saline solution, 250 cc | 4,509 | $1 | $10 |
| Injection, meropenem, 100 mg | 3,800 | $0 | $5 |
| 5% dextrose/water (500 ml = 1 unit) | 2,636 | $1 | $12 |
| Ceftriaxone antibiotic injection | 2,516 | $0 | $5 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,817 | $22 | $65 |
| Injection, ertapenem sodium, 500 mg | 1,635 | $11 | $120 |
| Office visit, established patient (20-29 min) | 1,044 | $68 | $125 |
| Blood draw (venipuncture) | 543 | $7 | $8 |
| Injection, vancomycin hcl, 500 mg | 477 | $2 | $10 |
| Hospital follow-up visit, moderate complexity | 471 | $63 | $175 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 351 | $16 | $40 |
| Injection, tobramycin sulfate, up to 80 mg | 343 | $2 | $10 |
| Office visit, established patient (30-39 min) | 281 | $95 | $175 |
| Office visit, established patient (10-19 min) | 244 | $43 | $75 |
| Injection of additional new drug or substance into vein | 229 | $12 | $75 |
| Initial hospital admission, moderate complexity | 120 | $103 | $324 |
| New patient office visit (45-59 min) | 77 | $124 | $200 |
| New patient office visit (30-44 min) | 72 | $84 | $150 |
| Initial hospital admission, high complexity | 69 | $135 | $450 |
| Hospital follow-up visit, high complexity | 28 | $94 | $250 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $40 | $80 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Damiani is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Damiani experienced with daptomycin antibiotic injection?
Does Dr. Damiani receive payments from pharmaceutical companies?
How do Dr. Damiani's costs compare to other infectious diseases in Port Charlotte?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology